Skip to main content
. 2013 Jun;98(6):980–987. doi: 10.3324/haematol.2012.075051

Figure 1.

Figure 1.

Cumulative incidence of grade 3–4 AEs and of drug discontinuation accounting for competing events (death and progressive disease). (A) Cumulative incidence of grade 3–4 non-hematologic toxicities. (B) Cumulative incidence of grade 3–4 infections, cardiac or gastrointestinal toxicities. (C) Cumulative incidence of drug discontinuation.